Article
Initial efficacy determination and resistance profile of anti- <i>Acinetobacter</i> antibiotics, turnercyclamycins
2021-11-03
Abstract excerpt
Drug-resistant Acinetobacter is a challenging, deadly pathogen of increasing prevalence in the US healthcare system. Recently, we described a series of lipopeptides, the turnercyclamycins, which retain potency against Acinetobacter strains that are resistant to the last-line antibiotic, colistin. To further evaluate the potential of turnercyclamycins, we completed mouse efficacy, pharmacokinetics, and toxicity s...
Topics
Open a Topic to create a Post that cites this publication.
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antimicrobial Peptides and Activities
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Berberine and alkaloids research
- Drug Transport and Resistance Mechanisms
- Microbial Metabolism and Applications
Identifiers and source
- Literature Corpus work
- 75a58490-8eb3-5904-8a74-b658eabd7288
- DOI
- 10.1101/2021.11.01.466777
